Virtus Fund Advisers’s AnaptysBio ANAB Stock Holding History

Virtus Fund Advisers’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$387K	Buy	+3,844	New	+$283K	﹤0.01%	368

Other funds holding ANAB

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Virtus Fund Advisers's ANAB Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in AnaptysBio (ANAB) in Q4 2017: 3,844 shares worth $387K. The stake represents ﹤0.01% of the portfolio and ranks #368 among its holdings.

116 funds tracked by Wall St. Rank hold ANAB as of Q4 2017.

Virtus Fund Advisers held 3,844 shares of AnaptysBio worth $387K as of Q4 2017.
AnaptysBio was a new Virtus Fund Advisers position in Q4 2017.
AnaptysBio made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #368 holding.
116 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.